Pazopanib Hydrochloride and Anastrozole Before Surgery in Treating Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

This study has been terminated.
(Slow accrual)
Sponsor:
Collaborators:
GlaxoSmithKline
Information provided by (Responsible Party):
University of Arizona
ClinicalTrials.gov Identifier:
NCT01394211
First received: June 28, 2011
Last updated: April 11, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)